Phase I dose-finding study of golvatinib (E7050), a c-Met and Eph receptor targeted multi-kinase inhibitor, administered orally QD to patients with advanced solid tumors.
Gennaro Daniele
No relevant relationships to disclose
Malcolm Ranson
No relevant relationships to disclose
Montserrat Blanco-Codesido
No relevant relationships to disclose
Emma Jane Dean
No relevant relationships to disclose
Krunal Jitendrakumar Shah
No relevant relationships to disclose
Matthew Krebs
No relevant relationships to disclose
Andre Brunetto
No relevant relationships to disclose
Alastair Greystoke
No relevant relationships to disclose
Claire Johnston
No relevant relationships to disclose
Galina Kuznetsov
Employment or Leadership Position - Eisai
Mark Matijevic
Employment or Leadership Position - Eisai
Bipin Mistry
Employment or Leadership Position - Eisai
Begona de las Heras
Employment or Leadership Position - Eisai
L Rhoda Molife
No relevant relationships to disclose